At LifeScan, our first responsibility is to the patients, healthcare professionals and all those who use OneTouch® Brand products. Our goal is to protect the health and safety of people with diabetes by maintaining a safe and secure supply chain and deterring illicit sources of supply.
Products obtained from sources not authorized by LifeScan have been found to be counterfeit, stored or transported improperly, tampered with, stolen, been associated with insurance fraud, illegally diverted or otherwise illegally obtained. Counterfeit and other grey market products may have been mishandled and could provide inaccurate readings which may lead to improper treatment decisions resulting in serious medical risk to patients.
If you think you have received counterfeit products, please contact customer service at 1-800-227-8862. Outside of U.S., please visit OneTouch.com/global and select your country.
Authorized Distributor List
Authorized Distributor List (Updated March 2020)
|AMERISOURCE BERGEN CORP
|CARDINAL HLTH MED PRODS &
|DAKOTA DRUG INC
|DDP MEDICAL SUPPLY
|DMS PHARMACEUTICAL GROUP, INC
|HENRY SCHEIN INC
|MEDLINE INDUSTRIES, INC
|MOORE MED CORP
|MORRIS & DICKSON CO LTD
|NORTH CAROLINA MUTUAL DRUG
|OWENS & MINOR, INC
|ROCHESTER DRUG COOP INC
|SMITH DRUG CO
|THE HARVARD DRUG GROUP
|VALUE DRUG CO
Call (800) 277-8862 to receive information on OneTouch® programs.
© 2020 LifeScan IP Holdings, LLC
Physician Payment Transparency
Relationships with Healthcare Professionals
Our relationship with Healthcare Professionals is part of our commitment to making life-changing, long-term differences in human health and disease management.
We partner with Healthcare Professionals through consulting service arrangements and royalty bearing product development agreements.
Consulting Services: Consultants provide us with invaluable insights in numerous areas of expertise, allowing us to improve the products and services available to patients in our continuing effort to improve patient outcomes. These service arrangements are important to obtain bona fide services or information from individuals who possess special knowledge, capabilities, expertise, qualifications, and/or experience. These consulting relationships with Healthcare Professionals may cover a variety of areas, including scientific research, product development and marketing services, advisory boards, training, the development of educational materials and disease management programs, data processing, and the ongoing safety surveillance of our products.
Royalties: Healthcare Professionals may provide contribution toward the development of new products or other technology and, in some cases, may be named as inventors on patents on our company’s products. Compensation for such contributions may involve the payment of a royalty, a percentage of applicable products’ sales, to the Healthcare Professional for a pre-determined period of time. Reported payments may reflect royalties earned in time periods prior to the posted period. Additionally, royalty payments may include interest payments resulting from delayed payments. Royalty recipients are not entitled to a royalty on their own purchases, or those of other colleagues at the same institution, of the royalty-bearing product.
Payments to Healthcare Professionals
All Healthcare Professionals are compensated based on fair market value standards for their qualifications and the amount of time spent providing services.
Arrangements are made in compliance with all applicable laws and codes in order to minimize actual or perceived conflicts of interests.
We are committed to working with only the most qualified individuals and select our speaking and consulting partners based upon their expertise in their given field.
Compliance with Applicable Laws and Codes
In our relationships, interactions with, and compensation provided to Healthcare Professionals, we observe all applicable laws and codes. We comply with the AdvaMed Code for Interactions with Healthcare Professionals and with FDA regulations to ensure that the product information is presented in a fair and balanced manner consistent with the approved product labeling, including both the product benefits and risks.